| Trial ID: | L0755 |
| Source ID: | CTRI/2019/03/018039
|
| Associated Drug: |
Katuki churna
|
| Title: |
A double blind randomized placebo controlled clinical trial for evaluating the efficacy of Bhunimba Kshara and Katuki Churna along with lifestyle modifications in the management of Non-Alcoholic Fatty Liver disease(NAFLD)
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention1: Bhunimba Kshara capsule 125 mg, BD<br>Katuki Churna capsule, 1g,HS: Bhunimba Kshara Capsule,125mg two tablets twice daily Orally for 30 days<br>Katuki churna capsule,1g, bedtime, orally, for 30 days<br>The medicines will be prepared accordi
|
| Outcome Measures: |
Changes in the infiltration of fat globules in Ultrasonography (USG) findings along with changes in clinical presentationsTimepoint: Zero <br/ ><br>Thirteith dayLiver function tests <br/ ><br>Lipid profile <br/ ><br>Changes in body weight, BMI and waist hip ratio <br/ ><br>Relief of the following symptoms like Fatigue, Pain in epigastrium, Anorexia, Nausea <br/ ><br>Overall improvement in quality of lifeTimepoint: Zero <br/ ><br>Thirty
|
| Sponsor/Collaborators: |
All India Institute of Ayurveda
|
| Gender: |
--
|
| Age: |
nannan
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
30
|
| Study Type: |
Interventional
|
| Study Designs: |
Randomized, Parallel Group, Placebo Controlled Trial<br> Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:An Open list of random numbers Blinding and masking:Participant and Investigator Blin
|
| Start Date: |
12/03/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
24 November 2021
|
| Locations: |
India
|
| URL: |
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=31042
|
